Appili Therapeutics' market value is the price at which a share of Appili Therapeutics trades on a public exchange. It measures the collective expectations of Appili Therapeutics investors about its performance. Appili Therapeutics is trading at 0.0149 as of the 25th of December 2025. This is a 17.22 percent decrease since the beginning of the trading day. The stock's lowest day price was 0.0148. With this module, you can estimate the performance of a buy and hold strategy of Appili Therapeutics and determine expected loss or profit from investing in Appili Therapeutics over a given investment horizon. Check out Appili Therapeutics Correlation, Appili Therapeutics Volatility and Appili Therapeutics Alpha and Beta module to complement your research on Appili Therapeutics.
Please note, there is a significant difference between Appili Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Appili Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Appili Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Appili Therapeutics 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Appili Therapeutics' pink sheet what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Appili Therapeutics.
0.00
11/25/2025
No Change 0.00
0.0
In 31 days
12/25/2025
0.00
If you would invest 0.00 in Appili Therapeutics on November 25, 2025 and sell it all today you would earn a total of 0.00 from holding Appili Therapeutics or generate 0.0% return on investment in Appili Therapeutics over 30 days. Appili Therapeutics is related to or competes with Innate Pharma, Brii Biosciences, Scancell Holdings, JW (Cayman), NervGen Pharma, Ascend Wellness, and Santhera Pharmaceuticals. Appili Therapeutics Inc., a biopharmaceutical company, focuses on the acquisition and development of novel medicines for... More
Appili Therapeutics Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Appili Therapeutics' pink sheet current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Appili Therapeutics upside and downside potential and time the market with a certain degree of confidence.
Today, many novice investors tend to focus exclusively on investment returns with little concern for Appili Therapeutics' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Appili Therapeutics' standard deviation. In reality, there are many statistical measures that can use Appili Therapeutics historical prices to predict the future Appili Therapeutics' volatility.
Appili Therapeutics is out of control given 3 months investment horizon. Appili Therapeutics secures Sharpe Ratio (or Efficiency) of 0.0693, which signifies that the company had a 0.0693 % return per unit of risk over the last 3 months. We were able to collect and analyze data for twenty-eight different technical indicators, which can help you to evaluate if expected returns of 1.01% are justified by taking the suggested risk. Use Appili Therapeutics Risk Adjusted Performance of 0.0826, downside deviation of 16.66, and Mean Deviation of 8.11 to evaluate company specific risk that cannot be diversified away. Appili Therapeutics holds a performance score of 5 on a scale of zero to a hundred. The firm shows a Beta (market volatility) of 1.34, which signifies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Appili Therapeutics will likely underperform. Use Appili Therapeutics downside variance, daily balance of power, and the relationship between the maximum drawdown and skewness , to analyze future returns on Appili Therapeutics.
Auto-correlation
0.41
Average predictability
Appili Therapeutics has average predictability. Overlapping area represents the amount of predictability between Appili Therapeutics time series from 25th of November 2025 to 10th of December 2025 and 10th of December 2025 to 25th of December 2025. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Appili Therapeutics price movement. The serial correlation of 0.41 indicates that just about 41.0% of current Appili Therapeutics price fluctuation can be explain by its past prices.
Correlation Coefficient
0.41
Spearman Rank Test
-0.36
Residual Average
0.0
Price Variance
0.0
Appili Therapeutics lagged returns against current returns
Autocorrelation, which is Appili Therapeutics pink sheet's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Appili Therapeutics' pink sheet expected returns. We can calculate the autocorrelation of Appili Therapeutics returns to help us make a trade decision. For example, suppose you find that Appili Therapeutics has exhibited high autocorrelation historically, and you observe that the pink sheet is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values
Timeline
Appili Therapeutics regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Appili Therapeutics pink sheet is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Appili Therapeutics pink sheet is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Appili Therapeutics pink sheet over time.
Current vs Lagged Prices
Timeline
Appili Therapeutics Lagged Returns
When evaluating Appili Therapeutics' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Appili Therapeutics pink sheet have on its future price. Appili Therapeutics autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Appili Therapeutics autocorrelation shows the relationship between Appili Therapeutics pink sheet current value and its past values and can show if there is a momentum factor associated with investing in Appili Therapeutics.
Other Information on Investing in Appili Pink Sheet
Appili Therapeutics financial ratios help investors to determine whether Appili Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Appili with respect to the benefits of owning Appili Therapeutics security.